Test Entry - Detail

Alzheimer's Disease


General
  Clinical Use: The Cerebrospinal Fluid (CSF) Assay (generation II) for Alzheimer Disease (AD) is an ante-mortem diagnostic test that detects alterations in biomarker protein levels, Abeta1-42, phospho-tau (P-tau), and total Tau (T-tau) in fresh CSF, which are believed to be directly related to the pathophysiology of Alzheimer's disease.
  Availability: Samples are batched and tested once a week.
  Aliases/Synonyms: Ab1-42,   Amyloid Beta,   Phospho-tau,   T-tau,  
  Code: ALZ
  Handling Instructions (to laboratory): Send sample chilled.
  Hyperlink: https://florey.edu.au/wp-content/uploads/2025/05/NDDL-AD-Specimen-Data-sheet.pdf
  Reference Interval:
Refer to report or laboratory


Collection Requirements
  Container: ALZ CSF Tube,  
  Sample Type: CSF
  Minimum Collection Volume:
  Collection Instructions: Special blue-capped tube must be used for collection, this container is not stocked or provided by PathWest.
Non-medicare rebateable item. All patients except Public, VA and Pensioners must pay $325 upfront.


Processing Requirements
  Alternate Containers:
  Processing Instructions: Do not freeze sample.
  Minimum Assay Volume:
  Stability: 1 week chilled
  Transport Instructions (to testing laboratory): Send sample chilled.
Provide routine cell counts and protein levels to testing laboratory.


Testing Locations
  Performed at:
Section Department Site Contact Phone
- Laboratory University of Melbourne (Florey Institute) (03) 9035 3000


Last Updated : 18-08-2025 14:28